Investigation of chromatin-bound CBX2-associated protein complexes in advanced cancer

Dr Mark Wade M.Wade@hull.ac.uk
Senior Lecturer in Molecular Genetics

The epigenetic regulatory protein CBX2 as a novel therapeutic target for glioblastoma multiform Sep 19, 2022 - Sep 18, 2025
PhD Studentship:

Glioblastoma (GBM) is the deadliest form of brain tumour, affecting 2-3 per 100,000 people each year. The average length of survival for GBM remain low at only 12-15 months following diagnosis, in part, due to a lack of targeted t... Read More about The epigenetic regulatory protein CBX2 as a novel therapeutic target for glioblastoma multiform.

Investigating the carcinogenic and epigenetic modulating effects of per- and poly-fluoroalkyl (PFAS) substances in breast cancer development Jan 1, 2024 - Dec 31, 2026
PFASs are used in numerous commercial and industrial applications. Subsequently, they are ubiquitously found in the environment and have been identified in human blood, breast milk and gut. They are endocrine disrupting chemicals which have been repo... Read More about Investigating the carcinogenic and epigenetic modulating effects of per- and poly-fluoroalkyl (PFAS) substances in breast cancer development.

Help 4 Health MSc studentships (2nd tranche) Feb 15, 2025 - Feb 1, 2027
Help 4 Health, through a competitive review process agreed to fund 3 MSc students (covering fees, a stipend of £16,062, and approximately £4k towards consumables).